A guidewire is a long and flexible wire (or spring in some cases) used to assist the introduction and proper placement of a larger medical device (particularly prosthesis) into a patient’s body. The guidewires used during any vascular procedure (a procedure involving cardiovascular system) are termed as vascular guidewires. Vascular guidewires are important during various surgical procedures (including placement of angioplasty balloons, stents, and inferior vena cava filters) as they guide a surgeon for the correct placement of these devices. Research Beam Model: Research Beam Product ID: 1544532 5370 USD New
Vascular Guidewires Market by Product and Coating Type - AMR

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Vascular Guidewires Market by Product (Coronary Guidewires and Peripheral Guidewires), Coating Type (Coated, and Non-Coated), and End User (Hospitals and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022

 
  • Category : Medical Devices
  • Published On : April  2017
  • Pages : 213
 
 

A guidewire is a long and flexible wire (or spring in some cases) used to assist the introduction and proper placement of a larger medical device (particularly prosthesis) into a patient’s body. The guidewires used during any vascular procedure (a procedure involving cardiovascular system) are termed as vascular guidewires. Vascular guidewires are important during various surgical procedures (including placement of angioplasty balloons, stents, and inferior vena cava filters) as they guide a surgeon for the correct placement of these devices.

The global vascular guidewires market was valued at $1,051 million in 2015, and is projected to reach $1,610 million by 2022, growing at a CAGR of 6.2% from 2016 to 2022. Rise in prevalence of cardiovascular disorders, increase in geriatric population, demand for minimally invasive procedures, and rapid technological advancements in guidewires drive the market growth. However, risks and complications associated with guidewires, and availability of effective conventional treatment options restrict the market growth. Conversely, increase in use of nitinol in vascular guidewires and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period.

The report segments the market based on product, coating type, end user, and region. Based on product, the market is bifurcated into coronary guidewires and peripheral guidewires. Based on coating type, it is divided into hydrophilic coating, hydrophobic coating, and non-coated. The end-user segment is bifurcated into hospitals and ambulatory surgical centers (ASCs). Based on region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS:

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders capitalize on prevailing market opportunities.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographical regions is provided, which determines the prevailing opportunities in these geographies.
  • Key players are profiled in the report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global market.

Vascular Guidewires Market Key Segments:

BY PRODUCT

  • Coronary Guidewires
  • Peripheral Guidewires

BY COATING TYPE

  • Coated
    • Hydrophilic Coating
    • Hydrophobic Coating
  • Non-coated

BY END USER

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

BY REGION

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • Medtronic plc
  • Terumo Corporation
  • The Spectranetics Corporation

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

  • Lepu Medical Technology (Beijing) Co., Ltd.
  • ASAHI INTECC CO., LTD.
  • BrosMed Medical Co., Ltd
  • JOTEC GmbH
  • Optimed Medizinische Instrumente GmbH

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing incidences of cardiac disorders and increasing geriatric population
3.4.1.2. Increasing patient awareness
3.4.1.3. Presence of high unmet medical needs

3.4.2. Restraints

3.4.2.1. Risks and complications associated with guidewires
3.4.2.2. Preference for drugs over treatment devices

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities in emerging economies
3.4.3.2. Use of nitinol in vascular guidewires

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 VASCULAR GUIDEWIRES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Key market tends
4.1.2. Key growth factors & opportunities
4.1.3. Market size & forecast
4.1.4. Coronary guidewires
4.1.5. Market size & forecast
4.1.6. Peripheral guidewires
4.1.7. Market size & forecast

CHAPTER 5 VASCULAR GUIDEWIRES MARKET, BY COATING TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. COATED

5.2.1. Hydrophilic Coatings
5.2.2. Hydrophobic coatings
5.2.3. Market size and forecast

5.3. NON-COATED

5.3.1. Market size and forecast

CHAPTER 6 VASCULAR GUIDEWIRES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS (ASCS)

6.3.1. Market size and forecast

CHAPTER 7 GLOBAL VASCULAR GUIDEWIRES MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Italy
7.3.8. Spain
7.3.9. Rest of Europe

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan
7.4.5. China
7.4.6. India
7.4.7. South Korea
7.4.8. Australia
7.4.9. Rest of Asia-Pacific

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. South Africa
7.5.6. Saudi Arabia
7.5.7. Rest of LAMEA

CHAPTER 8 COMPANY PROFILES

8.1 ABBOTT LABORATORIES

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4 Business Performance
8.1.5 Key Strategic Moves & Developments

8.2 B. BRAUN MELSUNGEN AG

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4 Business Performance
8.2.5 Key Strategic Moves & Developments

8.3 BOSTON SCIENTIFIC CORPORATION

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4 Business Performance
8.3.5 Key Strategic Moves & Developments

8.4 C. R. BARD, INC.

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4 Business Performance
8.4.5 Key Strategic Moves & Developments

8.5 CARDINAL HEALTH, INC.

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4 Business Performance
8.5.5 Key Strategic Moves & Developments

8.6 COOK MEDICAL, INC.

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4 Key Strategic Moves & Developments

8.7 MEDTRONIC PLC

8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4 Business Performance
8.7.5 Key Strategic Moves & Developments

8.8 BIOTRONIK SE & CO. KG

8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.5 Key Strategic Moves & Developments

8.9 TERUMO CORPORATION

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4 Business Performance
8.9.5 Key Strategic Moves & Developments

8.10 THE SPECTRANETICS CORPORATION

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4 Business Performance
8.10.5 Key Strategic Moves & Developments

LIST OF TABLES

TABLE 1. GLOBAL VASCULAR GUIDEWIRES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 2. GLOBAL CORONARY GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 3. NORTH AMERICA CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 4. EUROPE CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 5. ASIA-PACIFIC CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 6. LAMEA CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 7. GLOBAL PERIPHERAL GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. NORTH AMERICA PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 9. EUROPE PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 10. ASIA-PACIFIC PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 11. LAMEA PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 12. GLOBAL VASCULAR GUIDEWIRES MARKET, BY COATING TYPE ($MILLION), 2014-2022
TABLE 13. GLOBAL COATING TYPE VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 14. GLOBAL COATED VASCULAR GUIDEWIRES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 15. GLOBAL VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 16. HOSPITALS VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 17. AMBULATORY SURGICAL CENTERS (ASCS) VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 18. GLOBAL VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 19. GLOBAL VASCULAR GUIDEWIRES MARKET, BY REGION (THOUSAND UNITS), 2014-2022
TABLE 20. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 21. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 22. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 23. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 24. EUROPE VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 25. EUROPE VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 26. EUROPE VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 27. EUROPE VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 28. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 29. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 30. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 31. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 32. LAMEA VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 33. LAMEA VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 34. LAMEA VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
TABLE 35. LAMEA VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 36 ABBOTT: COMPANY SNAPSHOT
TABLE 37 ABBOTT: OPERATING SEGMENTS
TABLE 38 B. BRAUN: COMPANY SNAPSHOT
TABLE 39 B. BRAUN: OPERATING SEGMENTS
TABLE 40 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 41 BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 42 BARD: COMPANY SNAPSHOT
TABLE 43 BARD: OPERATING SEGMENTS
TABLE 44 CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 45 CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 46 COOK MEDICAL: COMPANY SNAPSHOT
TABLE 47 COOK MEDICAL: DIVISIONS
TABLE 48 MEDTRONIC: COMPANY SNAPSHOT
TABLE 49 MEDTRONIC: OPERATING SEGMENTS
TABLE 50 BIOTRONIK: COMPANY SNAPSHOT
TABLE 51 BIOTRONIK: OPERATING SEGMENTS
TABLE 52 TERUMO: COMPANY SNAPSHOT
TABLE 53 TERUMO: OPERATING SEGMENTS
TABLE 54 SPECTRANETICS: COMPANY SNAPSHOT
TABLE 55 SPECTRANETICS: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. VASCULAR GUIDEWIRES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, VASCULAR GUIDEWIRES MARKET, 2015
FIGURE 9. IMPACT ANALYSIS: VASCULAR GUIDEWIRES MARKET
FIGURE 10. CLINICAL TRIALS IN THE GLOBAL VASCULAR GUIDEWIRES MARKET
FIGURE 11. NORTH AMERICA: CLINICAL TRIALS FOR VASCULAR GUIDEWIRES, (%)
FIGURE 12. EUROPE: CLINICAL TRIALS FOR VASCULAR GUIDEWIRES, (%)
FIGURE 13. GLOBAL VASCULAR GUIDEWIRES MARKET, BY TYPE ($MILLION), 2014-2022
FIGURE 14. GLOBAL CORONARY GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 15. NORTH AMERICA CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 16. EUROPE CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 17. ASIA-PACIFIC CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 18. LAMEA CORONARY GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 19. GLOBAL PERIPHERAL GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 20. NORTH AMERICA PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 21. EUROPE PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 22. ASIA-PACIFIC PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 23. LAMEA PERIPHERAL GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 24. GLOBAL VASCULAR GUIDEWIRES MARKET, BY COATING TYPE ($MILLION), 2014-2022
FIGURE 25. GLOBAL COATING TYPE VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 26. GLOBAL COATED VASCULAR GUIDEWIRES MARKET, BY TYPE ($MILLION), 2014-2022
FIGURE 27. VASCULAR GUIDEWIRES MARKET FOR NON-COATED WIRES ($MILLION), 2014-2022
FIGURE 28. GLOBAL VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 29. HOSPITALS VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 30. AMBULATORY SURGICAL CENTERS (ASCS)VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 31. GLOBAL VASCULAR GUIDEWIRES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 32. GLOBAL VASCULAR GUIDEWIRES MARKET, BY REGION (THOUSAND UNITS), 2014-2022
FIGURE 33. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 34. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
FIGURE 35. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 36. NORTH AMERICA VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 37. U.S. VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 38. CANADA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 39. MEXICO VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 40. EUROPE VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 41. EUROPE VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
FIGURE 42. EUROPE VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 43. EUROPE VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 44. GERMANY VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 45. FRANCE VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 46. UK VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 47. ITALY VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 48. SPAIN VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 49. REST OF EUROPE VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 50. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 51. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
FIGURE 52. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 53. ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 54. JAPAN VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 55. CHINA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 56. INDIA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 57. SOUTH KOREA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 58. AUSTRALIA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 59. REST OF ASIA-PACIFIC VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 60. LAMEA VASCULAR GUIDEWIRES MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 61. LAMEA VASCULAR GUIDEWIRES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
FIGURE 62. LAMEA VASCULAR GUIDEWIRES MARKET, BY PRODUCT ($MILLION), 2014-2022
FIGURE 63. LAMEA VASCULAR GUIDEWIRES MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 64. BRAZIL VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 65. SOUTH AFRICA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 66. SAUDI ARABIA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 67. REST OF LAMEA VASCULAR GUIDEWIRES MARKET ($MILLION), 2014-2022
FIGURE 68 ABBOTT: NET SALES, 2013-2015 ($MILLION)
FIGURE 69 ABBOTT: NET SALES, BY SEGMENT, 2015 (%)
FIGURE 70 ABBOTT: NET SALES, BY GEOGRAPHY, 2015 (%)
FIGURE 71 B. BRAUN: NET SALES, 2013-2015 ($MILLION)
FIGURE 72 B. BRAUN: NET SALES, BY SEGMENT, 2015 (%)
FIGURE 73 B. BRAUN: NET SALES, BY GEOGRAPHY, 2015 (%)
FIGURE 74 BOSTON SCIENTIFIC: NET SALES, 2013-2015 ($MILLION)
FIGURE 75 BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2015 (%)
FIGURE 76 BOSTON SCIENTIFIC: NET SALES, BY GEOGRAPHY, 2015 (%)
FIGURE 77 BARD: NET SALES, 2013-2015 ($MILLION)
FIGURE 78 BARD: NET SALES, BY SEGMENT, 2015 (%)
FIGURE 79 BARD: NET SALES, BY GEOGRAPHY, 2015 (%)
FIGURE 80 CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
FIGURE 81 CARDINAL HEALTH: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 82 CARDINAL HEALTH: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 83 MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 84 MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 85 MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 86 TERUMO: NET SALES, 2014-2016 ($MILLION)
FIGURE 87 TERUMO: NET SALES, BY SEGMENT, 2016 (%)
FIGURE 88 TERUMO: NET SALES, BY GEOGRAPHY, 2016 (%)
FIGURE 89 SPECTRANETICS: NET SALES, 2013-2015 ($MILLION)
FIGURE 90 SPECTRANETICS: NET SALES, BY SEGMENT, 2015 (%)
FIGURE 91 SPECTRANETICS: NET SALES, BY PRODUCT LINE, 2015 (%)